E. M. Molnar
Impact in
- Pharmaceutical Science top 5%
- Advanced Drug Delivery Systems
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
Papers in
- Oncology 13
- Drug Transport and Resistance Mechanisms 12
- Co-authors
- John Tsibouklis (4 shared papers)Eugen Barbu (4 shared papers)Dariusz C. Górecki (3 shared papers)Péter Krajcsi (9 shared papers)Hristos Glavinas (3 shared papers)Emese Kis (4 shared papers)Tamás Janáky (3 shared papers)Krisztina Herédi‐Szabó (2 shared papers)
- Journals
- Journal of Pharmaceutical Sciences (2 papers)Biomacromolecules (2 papers)Thrombosis Research (2 papers)Expert Opinion on Drug Delivery (1 paper)Drug Metabolism and Disposition (1 paper)
- Partner nations
- HungaryUnited KingdomRussia
In The Last Decade
E. M. Molnar
37 papers receiving 749 citations
Peers
Comparison fields: 5 of 97
- Pharmaceutical Science 124
- Biomaterials 166
- Oncology 290
- Pediatrics, Perinatology and Child Health 101
- Molecular Medicine 25
Countries citing papers authored by E. M. Molnar
This map shows the geographic impact of E. M. Molnar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. M. Molnar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. M. Molnar more than expected).
Fields of papers citing papers by E. M. Molnar
This network shows the impact of papers produced by E. M. Molnar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. M. Molnar. The network helps show where E. M. Molnar may publish in the future.
Co-authors
The 25 scholars most cited alongside E. M. Molnar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 198 | |
| 2 | 2007 | 92 | |
| 3 | 2008 | 66 | |
| 4 | 2008 | 62 | |
| 5 | 2007 | 57 | |
| 6 | 2015 | 48 | |
| 7 | 2008 | 40 | |
| 8 | 2012 | 39 | |
| 9 | 2009 | 32 | |
| 10 | 2012 | 29 | |
| 11 | 2010 | 19 | |
| 12 | 2017 | 12 | |
| 13 | 2013 | 11 | |
| 14 | 2016 | 11 | |
| 15 | 2020 | 9 | |
| 16 | 2008 | 8 | |
| 17 | 2016 | 7 | |
| 18 | 2020 | 5 | |
| 19 | 2017 | 5 | |
| 20 | Simple ion exchange batch technique for detection of IgM antibodies against rubella and flavivirus antigens. | 1977 | 4 |
About E. M. Molnar
E. M. Molnar is a scholar working on Oncology, Epidemiology, Surgery, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine, having authored 44 papers that have together received 781 indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (12 papers), Nanoparticle-Based Drug Delivery (5 papers), Pharmacological Effects and Toxicity Studies (4 papers), Porphyrin and Phthalocyanine Chemistry (3 papers), Photodynamic Therapy Research Studies (3 papers), Barrier Structure and Function Studies (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Pharmaceutical Science (124 citations), Biomaterials (166 citations), Oncology (290 citations), Pediatrics, Perinatology and Child Health (101 citations) and Molecular Medicine (25 citations). E. M. Molnar has collaborated with scholars based in Hungary, United Kingdom and Russia. Frequent co-authors include John Tsibouklis, Eugen Barbu, Dariusz C. Górecki, Péter Krajcsi, Hristos Glavinas, Emese Kis, Tamás Janáky, Krisztina Herédi‐Szabó, Tünde Nagy and Lajos Szente. Their work appears in journals such as Journal of Pharmaceutical Sciences, Biomacromolecules, Thrombosis Research, Expert Opinion on Drug Delivery and Drug Metabolism and Disposition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.